Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebral bypass perfusion study: cardiac output versus blood pressure augmentation
NL-OMON46670Completed
- Sponsor
- Anesthesiologie
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dobutamine and phenylephrine in cerebrovascular disease, sponsored by Anesthesiologie. Primary endpoints: Mean change in graft flow rate during dobutamine administration and Mean change in graft flow rate during phenylephrine administration. Started Sep 2018; status: completed.
02
Drugs
dobutaminephenylephrine
03
Conditions
cerebrovascular disease
Beyond the preview
Go deeper on NL-OMON46670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46670.